BioSpace News Archive

Research Now SSI, a global leader in first-party data and data services, announces SamplePlus™ Meter solution

Viracor Eurofins announced the recent launch of a new 16S Next Generation Sequencing (NGS) Bacterial Meningitis test for use in patients suspected of having bacterial meningitis.

Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced it has entered into a collaboration agreement with the Paul Turner Lab at Yale University to manufacture and supply therapeutic bacteriophage (phage) for use in clinical trials.

Digital Pharmacist Inc., a rapidly growing digital health company, today unveiled a new short film, ‘Who Cares for America Today?’ by Sydney Gawlik.

For post-cancer surgery patients who develop lymphedema, swelling in the arms or legs may become their new normal.

Social determinants of health have significant downstream impacts on health outcomes and expenditures, yet healthcare practitioners struggle to assess patients’ social issues and connect them to an accountable network of community organizations that work collaboratively to address their needs.

The W. P. Carey School of Business at Arizona State University today announced plans to provide strategic recommendations to the nation’s military to improve patient care for service members.

CDISC and Cohen Veterans Bioscience are pleased to announce the publication of a new Therapeutic Area (TA) Standard for Post Traumatic Stress Disorder released in the form of a User Guide for data managers, statisticians, programmers and study managers.

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that the first patient was treated in a phase 1 dose escalation study combining pelareorep and carfilzomib with Bristol-Myers Squibb’s checkpoint inhibitor Opdivo®(nivolumab) to treat relapsed multiple myeloma patients.

The International Society for Medical Publication Professionals (ISMPP) and the Pharma Collaboration for Transparent Medical Information (phactMITM) are pleased to announce their new partnership focused on enhancing the value of scientific communications through the collaboration of medical publication and medical information professionals.